Clinical Laboratory Testing: Keeping Up With CLIA (2025 Update)-Clinical Laboratory Testing Keeping Up With CLIA (2025 Update)

Clinical Laboratory Testing Keeping Up With CLIA (2025 Update)

Pdf Summary

The article explains why clinical laboratory testing is central to modern health care and how U.S. laboratories are regulated under the Clinical Laboratory Improvement Amendments (CLIA) of 1988, enacted after concerns about inaccurate Pap test results. CLIA, administered by the Centers for Medicare & Medicaid Services (CMS), applies to virtually all patient testing outside research settings and regulates laboratories based on test complexity rather than location. As of 2025, about 320,000 laboratories fall under CLIA, including physician offices, hospitals, and independent labs.<br /><br />It outlines three CLIA test categories—waived, moderate complexity, and high complexity—emphasizing that most physician office labs perform waived tests. Waived tests are considered low risk and have fewer regulatory requirements, but they must be performed exactly according to manufacturer instructions and require a CMS certificate of waiver. Common waived point-of-care tests include glucose, cholesterol, dipstick urinalysis, fecal occult blood, and rapid infectious disease tests (e.g., influenza, strep A). The article notes that improved devices have expanded office-based testing, but waived tests can have important limitations (e.g., glucose meters may miss dangerously low glucose), making staff education and confirmatory testing at central labs essential.<br /><br />Although waived labs are not routinely inspected, CMS can inspect a percentage, and “hidden” requirements (such as documenting temperature/humidity ranges specified by manufacturers) can create recordkeeping obligations. Moderate/high complexity testing requires stricter personnel standards, quality control, proficiency testing, and biennial inspections by approved accrediting bodies, with higher fees.<br /><br />The piece highlights the value of proficiency testing as a benchmarking tool (even for waived sites) and stresses the importance of written procedure manuals—required for moderate/high complexity labs and recommended for waived labs—to reduce errors, support training, and standardize steps and timing. Finally, it underscores documentation and follow-through in ordering and tracking outside lab tests, portraying medical assistants and support staff as essential to compliance, accuracy, and patient advocacy.

Keywords

clinical laboratory testing

CLIA 1988

Centers for Medicare & Medicaid Services (CMS)

laboratory regulation

waived tests

moderate complexity testing

high complexity testing

point-of-care testing

proficiency testing

quality control and documentation